Societe Generale Reiterates “Buy” Rating for Halliburton Company (HAL.F)

Share on StockTwits

Halliburton Company (NASDAQ: HAL.F)‘s stock had its “buy” rating restated by research analysts at Societe Generale in a report released on Friday, Stock Ratings Network.com reports. They currently have a $55.00 price objective on the stock.

Shares of Halliburton Company (NASDAQ: HAL.F) traded up 1.51% during mid-day trading on Friday, hitting $32.276. Halliburton Company has a 52 week low of $21.20 and a 52 week high of $35.638. The stock’s 50-day moving average is currently $27.07.

A number of other firms have also recently commented on HAL.F. Analysts at UBS AG raised their price target on shares of Halliburton Company from $48.00 to $53.00 in a research note to investors on Wednesday, March 27th. They now have a “buy” rating on the stock. Analysts at Guggenheim upgraded shares of Halliburton Company from a “neutral” rating to a “buy” rating in a research note to investors on Thursday, March 21st. They now have a $48.00 price target on the stock, up previously from $42.00.

Five research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and an average target price of $52.00.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be paid a dividend of $0.13 per share. This represents a $0.50 annualized dividend and a dividend yield of Infinity.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

Windows 10 Scam Being Sent Via Email
Windows 10 Scam Being Sent Via Email
FireEye Shares Drop Prior to Opening Bell on CFO Departure
FireEye Shares Drop Prior to Opening Bell on CFO Departure
Goodyear Profit Exceeds Estimates on Demand in North America
Goodyear Profit Exceeds Estimates on Demand in North America
Allergen Bid Might Be Better for Teva
Allergen Bid Might Be Better for Teva
Biogen Slashes Forecast on Weakness of Tecfidera
Biogen Slashes Forecast on Weakness of Tecfidera
Whirlpool Profit for the Quarter Drops on Strong Dollar
Whirlpool Profit for the Quarter Drops on Strong Dollar


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.